Flexion Therapeutics, Inc. Accounts Receivable
Flexion Therapeutics, Inc. had Accounts Receivable of $29.38 million as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2021-11-12
- 2021-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $29.38M.
- 2021-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $35.10M.
- 2021-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $30.36M.
- 2020-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $30.02M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2021-09-30 | $29.38M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $35.10M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $30.36M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $30.02M 10-Q · filed 2021-11-12 |
| 2020-09-30 | $27.90M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $21.52M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $30.36M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $37.12M 10-K · filed 2021-03-10 |
| 2019-09-30 | $29.32M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $22.59M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $15.13M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $13.12M 8-K · filed 2020-05-20 |
| 2018-09-30 | $8.80M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $5.06M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $2.40M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $410.00K 10-K · filed 2019-02-28 |